FIELD: medicine.
SUBSTANCE: method for the treatment of a subject suffering from Smith-Lemley-Opitz syndrome (hereinafter – SLOS) is proposed, including the administration of the effective amount of a compound modulating NMDA receptor to the subject.
EFFECT: invention provides for the effective treatment of SLOS.
15 cl
| Title | Year | Author | Number |
|---|---|---|---|
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
| NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
| NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
| NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
| 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
| 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2812930C2 |
| 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USING THEM | 2014 |
|
RU2700264C2 |
